Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
This position plays a key role supporting many aspects of Nevro’s compliance program, including identifying and mitigating risk though the design, implementation, and execution of Nevro’s healthcare compliance program to ensure compliance with applicable laws and regulations. This position is based in Redwood City, CA at Nevro’s headquarters and reports to Nevro’s Director of Compliance.